17-8312233-C-T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_173728.4(ARHGEF15):​c.194C>T​(p.Pro65Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,514,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. P65P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000069 ( 0 hom., cov: 24)
Exomes 𝑓: 0.000010 ( 0 hom. )

Consequence

ARHGEF15
NM_173728.4 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.38

Publications

0 publications found
Variant links:
Genes affected
ARHGEF15 (HGNC:15590): (Rho guanine nucleotide exchange factor 15) Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein-coupled receptors. This gene encodes a protein that functions as a specific guanine nucleotide exchange factor for RhoA. It also interacts with ephrin A4 in vascular smooth muscle cells. Two alternatively spliced transcripts variants that encode the same protein have been found for this gene. [provided by RefSeq, Aug 2010]
ARHGEF15 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • schizophrenia
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.17055893).
BS2
High AC in GnomAdExome4 at 14 Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARHGEF15NM_173728.4 linkc.194C>T p.Pro65Leu missense_variant Exon 2 of 16 ENST00000361926.8 NP_776089.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARHGEF15ENST00000361926.8 linkc.194C>T p.Pro65Leu missense_variant Exon 2 of 16 1 NM_173728.4 ENSP00000355026.3

Frequencies

GnomAD3 genomes
AF:
0.00000685
AC:
1
AN:
145980
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000151
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000190
AC:
4
AN:
210976
AF XY:
0.0000178
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000420
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000102
AC:
14
AN:
1368034
Hom.:
0
Cov.:
36
AF XY:
0.0000103
AC XY:
7
AN XY:
676832
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31066
American (AMR)
AF:
0.00
AC:
0
AN:
38646
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21180
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38230
South Asian (SAS)
AF:
0.00
AC:
0
AN:
77604
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47278
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5270
European-Non Finnish (NFE)
AF:
0.0000123
AC:
13
AN:
1053468
Other (OTH)
AF:
0.0000181
AC:
1
AN:
55292
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000685
AC:
1
AN:
145980
Hom.:
0
Cov.:
24
AF XY:
0.00
AC XY:
0
AN XY:
70816
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
39568
American (AMR)
AF:
0.00
AC:
0
AN:
14434
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3420
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4998
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4286
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9768
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
310
European-Non Finnish (NFE)
AF:
0.0000151
AC:
1
AN:
66300
Other (OTH)
AF:
0.00
AC:
0
AN:
2008
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 19, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.194C>T (p.P65L) alteration is located in exon 2 (coding exon 1) of the ARHGEF15 gene. This alteration results from a C to T substitution at nucleotide position 194, causing the proline (P) at amino acid position 65 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Developmental and epileptic encephalopathy Uncertain:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 65 of the ARHGEF15 protein (p.Pro65Leu). This variant is present in population databases (rs747885678, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with ARHGEF15-related conditions. ClinVar contains an entry for this variant (Variation ID: 575505). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.36
CADD
Uncertain
26
DANN
Benign
0.67
DEOGEN2
Benign
0.056
.;T;.;T
Eigen
Benign
-0.12
Eigen_PC
Benign
-0.065
FATHMM_MKL
Benign
0.56
D
LIST_S2
Benign
0.84
T;.;T;T
M_CAP
Uncertain
0.098
D
MetaRNN
Benign
0.17
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.0
.;L;.;L
PhyloP100
2.4
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-2.3
.;N;.;N
REVEL
Benign
0.088
Sift
Uncertain
0.0010
.;D;.;D
Sift4G
Uncertain
0.0050
D;D;D;D
Polyphen
0.084
.;B;.;B
Vest4
0.42, 0.42
MutPred
0.23
Gain of helix (P = 0.0164);Gain of helix (P = 0.0164);Gain of helix (P = 0.0164);Gain of helix (P = 0.0164);
MVP
0.78
MPC
0.46
ClinPred
0.58
D
GERP RS
4.2
Varity_R
0.088
gMVP
0.35
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs747885678; hg19: chr17-8215551; API